JP4525221B2 - 受容体リガンド同定法 - Google Patents

受容体リガンド同定法 Download PDF

Info

Publication number
JP4525221B2
JP4525221B2 JP2004210868A JP2004210868A JP4525221B2 JP 4525221 B2 JP4525221 B2 JP 4525221B2 JP 2004210868 A JP2004210868 A JP 2004210868A JP 2004210868 A JP2004210868 A JP 2004210868A JP 4525221 B2 JP4525221 B2 JP 4525221B2
Authority
JP
Japan
Prior art keywords
group
nuclear receptor
substituted
pparγ
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004210868A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006030037A5 (enExample
JP2006030037A (ja
Inventor
琢磨 白木
成敏 神谷
久人 陣上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Priority to JP2004210868A priority Critical patent/JP4525221B2/ja
Publication of JP2006030037A publication Critical patent/JP2006030037A/ja
Publication of JP2006030037A5 publication Critical patent/JP2006030037A5/ja
Application granted granted Critical
Publication of JP4525221B2 publication Critical patent/JP4525221B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2004210868A 2004-07-16 2004-07-16 受容体リガンド同定法 Expired - Fee Related JP4525221B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004210868A JP4525221B2 (ja) 2004-07-16 2004-07-16 受容体リガンド同定法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004210868A JP4525221B2 (ja) 2004-07-16 2004-07-16 受容体リガンド同定法

Publications (3)

Publication Number Publication Date
JP2006030037A JP2006030037A (ja) 2006-02-02
JP2006030037A5 JP2006030037A5 (enExample) 2007-08-23
JP4525221B2 true JP4525221B2 (ja) 2010-08-18

Family

ID=35896572

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004210868A Expired - Fee Related JP4525221B2 (ja) 2004-07-16 2004-07-16 受容体リガンド同定法

Country Status (1)

Country Link
JP (1) JP4525221B2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2181710A1 (en) * 2008-10-28 2010-05-05 Phenex Pharmaceuticals AG Ligands for modulation of orphan receptor-gamma (NR1F3) activity
JP2011037739A (ja) * 2009-08-10 2011-02-24 Pola Chemical Industries Inc 組成物
WO2014026330A1 (en) * 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
JP2023047726A (ja) * 2021-09-27 2023-04-06 富士通株式会社 初期構造生成装置、初期構造生成方法及び初期構造生成プログラム
WO2024204454A1 (ja) * 2023-03-29 2024-10-03 国立研究開発法人理化学研究所 融合タンパク質

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002102364A1 (ja) * 2001-06-18 2004-09-30 山田　幸子 ＰＰＡＲγ作動性医薬組成物
KR101021817B1 (ko) * 2001-07-17 2011-03-17 데이진 가부시키가이샤 ＰＰＡＲ δ활성화 작용을 측정하는 것을 특징으로 하는 물질의 선택방법 및 약제
GB0119920D0 (en) * 2001-08-15 2001-10-10 Pfizer Ltd New use

Also Published As

Publication number Publication date
JP2006030037A (ja) 2006-02-02

Similar Documents

Publication Publication Date Title
Dixon et al. Predicting the structural basis of targeted protein degradation by integrating molecular dynamics simulations with structural mass spectrometry
Nady et al. Histone recognition by human malignant brain tumor domains
AU2003274330B2 (en) Asparaginyl hydroxylases and modulators thereof
Nithianantham et al. Tubulin cofactors and Arl2 are cage-like chaperones that regulate the soluble αβ-tubulin pool for microtubule dynamics
Menchaca et al. Past, present, and future of molecular docking
JP2003511467A (ja) アンドロゲンレセプターリガンド結合ドメインの結晶構造
Jin et al. Communication between the ligand-binding pocket and the activation function-2 domain of androgen receptor revealed by molecular dynamics simulations
Ogburn et al. Discovery of tamoxifen and N-desmethyl tamoxifen protein targets in MCF-7 cells using large-scale protein folding and stability measurements
Bragantini et al. Functional and structural insights of the zinc-finger HIT protein family members involved in box C/D snoRNP biogenesis
Karttunen et al. Prediction of binding energy of Keap1 interaction motifs in the Nrf2 antioxidant pathway and design of potential high-affinity peptides
Murcia Rios et al. Evidence for a partially stalled γ rotor in F1-ATPase from hydrogen–deuterium exchange experiments and molecular dynamics simulations
Panel et al. A simple PB/LIE free energy function accurately predicts the peptide binding specificity of the Tiam1 PDZ domain
Hu et al. Metal binding mediated conformational change of XPA protein: a potential cytotoxic mechanism of nickel in the nucleotide excision repair
Han et al. Understanding the phosphorylation mechanism by using quantum chemical calculations and molecular dynamics simulations
Alvarez-Garcia et al. Extracting atomic contributions to binding free energy using molecular dynamics simulations with mixed solvents (MDmix)
JP4525221B2 (ja) 受容体リガンド同定法
Cole et al. Interrogation of the protein-protein interactions between human BRCA2 BRC repeats and RAD51 reveals atomistic determinants of affinity
Yu et al. The Crystal Structure of Calmodulin Bound to the Cardiac Ryanodine Receptor (RyR2) at Residues Phe4246–Val4271 Reveals a Fifth Calcium Binding Site
Lwin et al. A fluid salt-bridging cluster and the stabilization of p53
Ma et al. Inhibition of CYP2C8 by metallofullerenol Gd@ C82 (OH) 22 through blocking substrate channels and substrate recognition sites
WO2011033322A2 (en) Crystal structure
Cardone et al. Structural and dynamic determinants of ligand binding and regulation of cyclin-dependent kinase 5 by pathological activator p25 and inhibitory peptide CIP
Novack et al. Oncogenic mutations in the DNA-binding domain of FOXO1 that disrupt folding: quantitative insights from experiments and molecular simulations
Inverardi et al. Adsorption of silica oligomers on biomolecules: Structural and dynamical insights for atom probe tomography via classic molecular dynamics simulations
Zuo et al. Calculations of the free energy of interaction of the c-Fos− c-Jun coiled coil: Effects of the solvation model and the inclusion of polarization effects

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20060221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060221

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20070510

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20070514

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070629

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070629

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090917

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091006

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091202

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100413

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100416

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100511

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100524

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130611

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130611

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130611

Year of fee payment: 3

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130611

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees